Indian drugmaker Dr. Reddy's Laboratories Ltd said on Friday it expects to get 36 million doses of Sputnik V COVID-19 vaccine in the next couple of months under its contract with Russia's sovereign wealth fund.
India's catastrophic second wave of the pandemic has led to huge demand for vaccines, which in turn has left the country, the world's biggest vaccine producer, low on stocks.
"We are in discussions with the Russian Direct Investment Fund (RDIF) to import the vaccine towards the end of May," a senior Dr. Reddy's executive said on a post-earnings press conference.
"Our total commitment contracted from
Disclaimer: No Business Standard Journalist was involved in creation of this content